According to well being Key , greater than 50% of Bangkok’s inhabitants are fatties and consider there’s a urgent need to address the health of lard-arsed residents not only within the capital however all through the Kingdom of Thailand.
Fortunately, there are people out there who care and need to stop the fat folks of Bangkok, and Thailand, from getting fatter and dying due to being overweight.
The Thai NCDs Network Association, in collaboration with Novo Nordisk Pharma (Thailand) Co., Ltd., hosted a seminar titled OBESITY: A Public Health Crisis on the Thai Annual Conference NCD Alliance 2023, which centred on the theme Fighting the Obesity Pandemic. The occasion was attended by medical professionals from everywhere in the country and took place at the True Icon Hall, Icon Siam in Bangkok, reported Bangkok Post
During the seminar, members mentioned various aspects of the obesity disaster, together with the monetary burden that the federal government must bear. The urgency of addressing this problem in all sectors has prompted the necessity for insurance policies aimed at preventing weight problems, in addition to clear and efficient treatment guidelines to deal with the needs of this patient inhabitants.
Obesity is a important well being concern that requires immediate attention as a outcome of its association with over 200 other critical complications, including diabetes, high blood pressure, excess body fat, heart disease, dementia, and others. Unfortunately, weight problems rates in Thailand proceed to rise.
According to a survey performed in 2020, the prevalence of obesity has reached alarming ranges, with rates as high as 42%, and even higher in Bangkok at 56%.
In comparison, the remainder of Thailand has an weight problems price of 50%. If left unchecked, this trend will have a significant impression on public health. Therefore, it’s crucial for the personal and non-private sectors to work together to search out methods to forestall and tackle the obesity disaster.
Enrico Cañal Bruland, Vice President & General Manager of Novo Nordisk Pharma (Thailand) Co., Ltd., mentioned Novo is dedicated to driving change for people dwelling with weight problems in Thailand.
“We have invested significantly in analysis and development, including local studies here in Thailand, and we’ve accelerated access to our progressive medicines for individuals dwelling with obesity.”
Prof Wannee Nitiyanant, President of the Diabetes Association of Thailand, reported that the price burden of obesity is big, with an amazing monetary influence on society.
“In Thailand, this situation requires urgent motion to sort out this illness and the time to behave is now. The sustainability of the Thai healthcare system is decided by our success in curbing this weight problems crisis, in any other case, the system will soon be overwhelmed by the exponential trajectory of direct and oblique prices.
“For Thailand, the general healthcare spending sits at 6.6% of GDP, while 1.5% of GDP is dedicated to obesity and its related issues. If we don’t act, this number alone will rise to 6.4% of GDP primarily based on recent knowledge. This will certainly affect everybody in our technology here in Thailand.”
Experts decided that the population of Bangkok, in phrases of obesity, is about 5.5 million people. Among individuals aged 20-69 with a body mass index (BMI) between 30 and 50, there are about 356,000 individuals who, if they lose 10% of their weight over the subsequent decade, may save up to 2 billion baht on medical expenses.
The government, by way of the Centers for Disease Control, has taken steps to manage weight problems within the healthcare system by way of the “NCD Clinic Plus” program, which handles weight control in sufferers with underlying diseases, and has established workplace policies and techniques to encourage authorities agencies and personal organizations to have good well being insurance policies for their staff. Additionally, there is a push for the implementation of “NCD Clinic Plus” in sub-district hospitals for well being promotion, as well as in quite a few different sectors.
Currently, weight problems surgical procedure may be reimbursed (depending on medical remedy rights) for patients with a BMI of 37.5 (without comorbidities) or 32.5+ with one or more comorbidities. However, there are at present no clear standards for the reimbursement of obesity medication.
If the long-term results of weight problems on both patients and the economy are thought-about, having clear pointers and necessities for the remedy of obesity will result in the greatest future benefit when it comes to reimbursement of medical bills for overweight sufferers via the “always fee mechanism associated to medical service.”
Therefore, No strings attached and research on the health-economic worth (cost-effectiveness) of treating sufferers (such as behaviour modification or drugs for obesity treatment) are essential for further concerns beyond surgery..